Proficio Capital Partners LLC Invests $480,000 in iShares Biotechnology ETF (NASDAQ:IBB)

Proficio Capital Partners LLC acquired a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to the company in its most recent filing with the SEC. The fund acquired 3,633 shares of the financial services provider’s stock, valued at approximately $480,000.

A number of other institutional investors also recently modified their holdings of the stock. HHM Wealth Advisors LLC boosted its holdings in iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 150 shares in the last quarter. Bradley & Co. Private Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the 4th quarter worth $32,000. Newbridge Financial Services Group Inc. bought a new position in shares of iShares Biotechnology ETF in the 4th quarter worth $33,000. Hager Investment Management Services LLC bought a new stake in iShares Biotechnology ETF during the 4th quarter valued at $34,000. Finally, Modus Advisors LLC bought a new stake in iShares Biotechnology ETF during the 4th quarter valued at $41,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 1.3 %

iShares Biotechnology ETF stock opened at $135.31 on Tuesday. The firm has a market capitalization of $6.39 billion, a price-to-earnings ratio of 27.83 and a beta of 0.84. The firm’s fifty day moving average price is $136.25 and its two-hundred day moving average price is $139.23. iShares Biotechnology ETF has a 1-year low of $123.60 and a 1-year high of $150.57.

iShares Biotechnology ETF Increases Dividend

The firm also recently declared a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were given a $0.1212 dividend. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date was Tuesday, March 18th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.